CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited)	9 Months Ended
	Sep. 30, 2022 USD ($)
Cash flows from operating activities
Net increase in net assets resulting from operations	$ 1,500,131
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments	(135,023,930)
Proceeds from sales and repayments of investments	6,925,278
Net change in unrealized depreciation on investments	713,013
Net change in unrealized appreciation on foreign currency translation	104,461
Amortization of premium and accretion of discount, net	(114,567)
Amortization of loan structure fees	277,541
Amortization of deferred offering costs	164,982
Changes in other assets and liabilities
Increase in interest receivable	(861,191)
Increase in receivable from related party	(43,105)
Increase in expense reimbursements receivable from the Advisor	(324,831)
Decrease in prepaid expenses	50,650
Decrease in due to affiliate	(460,085)
Decrease in trustees' fees payable	(42,000)
Increase in administrative services payable	106,190
Increase in interest payable	233,971
Increase in income incentive fees payable	246,156
Increase in unearned revenue	498,153
Decrease in other accrued expenses and liabilities	(173,855)
Net Cash Used In Operating Activities	(127,469,781)
Cash flows from Financing Activities
Proceeds from the issuance of common shares of beneficial interest	76,354,327
Offering costs paid for common shares of beneficial interest issued	(139,542)
Borrowings under Credit Facility	90,290,000
Repayments of Credit Facility	(34,890,000)
Financing costs paid on Credit facility	(1,236,457)
Short-term loan borrowings	9,000,000
Net Cash Provided by Financing Activities	138,603,775
Net Increase in Cash and Cash Equivalents	11,133,994
Cash and Cash Equivalents Balance at End of Period	11,133,994
Supplemental and Non-Cash Activities
Cash paid for interest expense	$ 4,328